SPX4,280.15+72.88 1.73%
DIA337.83+4.12 1.23%
IXIC13,047.19+267.27 2.09%

Alnylam Pharmaceuticals Q2 Adjusted Loss Widens, Revenue Increases; Shares Down Pre-Bell

Alnylam Pharmaceuticals Q2 Adjusted Loss Widens, Revenue Increases; Shares Down Pre-Bell

MT Newswires · 07/28/2022 04:37

Please log in to view news